Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
26 | 34145 | 37.9 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HEPATITIS C VIRUS | authKW | 3083106 | 15% | 66% | 5204 |
2 | HEPATITIS C | authKW | 2058212 | 11% | 60% | 3833 |
3 | HCV | authKW | 1411494 | 7% | 62% | 2545 |
4 | RIBAVIRIN | authKW | 886813 | 4% | 65% | 1521 |
5 | CHRONIC HEPATITIS C | authKW | 874858 | 4% | 66% | 1497 |
6 | JOURNAL OF VIRAL HEPATITIS | journal | 484110 | 3% | 50% | 1095 |
7 | GASTROENTEROLOGY & HEPATOLOGY | WoSSC | 362921 | 31% | 4% | 10709 |
8 | PEGYLATED INTERFERON | authKW | 279655 | 1% | 69% | 454 |
9 | DIRECT ACTING ANTIVIRALS | authKW | 276525 | 1% | 95% | 327 |
10 | INTERFERON | authKW | 261334 | 4% | 20% | 1479 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 362921 | 31% | 4% | 10709 |
2 | Virology | 214059 | 19% | 4% | 6590 |
3 | Infectious Diseases | 64722 | 14% | 2% | 4620 |
4 | Transplantation | 16119 | 5% | 1% | 1668 |
5 | Immunology | 15052 | 12% | 1% | 3996 |
6 | Microbiology | 5838 | 7% | 0% | 2349 |
7 | Medicine, General & Internal | 5286 | 7% | 0% | 2528 |
8 | Pharmacology & Pharmacy | 1715 | 7% | 0% | 2352 |
9 | Urology & Nephrology | 1204 | 3% | 0% | 858 |
10 | Hematology | 939 | 2% | 0% | 837 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEPATOL | 150873 | 3% | 17% | 1010 |
2 | GASTROENTEROL HEPATOL | 120082 | 6% | 7% | 2055 |
3 | STUDY HEPATITIS C | 120062 | 1% | 68% | 199 |
4 | LIVER DIS | 77022 | 1% | 19% | 462 |
5 | LIVER UNIT | 75824 | 2% | 14% | 630 |
6 | INFECT DIS | 67274 | 7% | 3% | 2464 |
7 | SERV HEPATOL | 64057 | 1% | 25% | 285 |
8 | VIRAL HEPATITIS | 63416 | 1% | 29% | 245 |
9 | VIROL | 61863 | 5% | 5% | 1543 |
10 | GASTROENTEROL | 59779 | 7% | 3% | 2322 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF VIRAL HEPATITIS | 484110 | 3% | 50% | 1095 |
2 | JOURNAL OF HEPATOLOGY | 147341 | 3% | 15% | 1123 |
3 | HEPATOLOGY | 123454 | 4% | 11% | 1288 |
4 | JOURNAL OF MEDICAL VIROLOGY | 112643 | 3% | 13% | 985 |
5 | HEPATITIS MONTHLY | 57656 | 1% | 29% | 228 |
6 | LIVER INTERNATIONAL | 54620 | 1% | 16% | 396 |
7 | HEPATOLOGY RESEARCH | 53861 | 1% | 15% | 403 |
8 | ANTIVIRAL THERAPY | 45635 | 1% | 17% | 311 |
9 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 21227 | 1% | 6% | 402 |
10 | ANNALS OF HEPATOLOGY | 18832 | 0% | 17% | 126 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEPATITIS C VIRUS | 3083106 | 15% | 66% | 5204 | Search HEPATITIS+C+VIRUS | Search HEPATITIS+C+VIRUS |
2 | HEPATITIS C | 2058212 | 11% | 60% | 3833 | Search HEPATITIS+C | Search HEPATITIS+C |
3 | HCV | 1411494 | 7% | 62% | 2545 | Search HCV | Search HCV |
4 | RIBAVIRIN | 886813 | 4% | 65% | 1521 | Search RIBAVIRIN | Search RIBAVIRIN |
5 | CHRONIC HEPATITIS C | 874858 | 4% | 66% | 1497 | Search CHRONIC+HEPATITIS+C | Search CHRONIC+HEPATITIS+C |
6 | PEGYLATED INTERFERON | 279655 | 1% | 69% | 454 | Search PEGYLATED+INTERFERON | Search PEGYLATED+INTERFERON |
7 | DIRECT ACTING ANTIVIRALS | 276525 | 1% | 95% | 327 | Search DIRECT+ACTING+ANTIVIRALS | Search DIRECT+ACTING+ANTIVIRALS |
8 | INTERFERON | 261334 | 4% | 20% | 1479 | Search INTERFERON | Search INTERFERON |
9 | TELAPREVIR | 259473 | 1% | 93% | 314 | Search TELAPREVIR | Search TELAPREVIR |
10 | SUSTAINED VIROLOGICAL RESPONSE | 250995 | 1% | 86% | 327 | Search SUSTAINED+VIROLOGICAL+RESPONSE | Search SUSTAINED+VIROLOGICAL+RESPONSE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GHANY, MG , STRADER, DB , THOMAS, DL , SEEFF, LB , (2009) DIAGNOSIS, MANAGEMENT, AND TREATMENT OF HEPATITIS C: AN UPDATE.HEPATOLOGY. VOL. 49. ISSUE 4. P. 1335-1374 | 301 | 81% | 1767 |
2 | SOFIA, MJ , CHANG, WS , FURMAN, PA , MOSLEY, RT , ROSS, BS , (2012) NUCLEOSIDE, NUCLEOTIDE, AND NON-NUCLEOSIDE INHIBITORS OF HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA-POLYMERASE.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 55. ISSUE 6. P. 2481-2531 | 273 | 83% | 112 |
3 | GOTTWEIN, JM , BUKH, J , (2008) CUTTING THE GORDIAN KNOT-DEVELOPMENT AND BIOLOGICAL RELEVANCE OF HEPATITIS C VIRUS CELL CULTURE SYSTEMS.ADVANCES IN VIRUS RESEARCH, VOL 71. VOL. 71. ISSUE . P. 51-+ | 399 | 84% | 33 |
4 | SARRAZIN, C , (2016) THE IMPORTANCE OF RESISTANCE TO DIRECT ANTIVIRAL DRUGS IN HCV INFECTION IN CLINICAL PRACTICE.JOURNAL OF HEPATOLOGY. VOL. 64. ISSUE 2. P. 486 -504 | 101 | 97% | 46 |
5 | DIENSTAG, JL , MCHUTCHISON, JG , (2006) AMERICAN GASTROENTEROLOGICAL ASSOCIATION TECHNICAL REVIEW ON THE MANAGEMENT OF HEPATITIS C.GASTROENTEROLOGY. VOL. 130. ISSUE 1. P. 231-264 | 285 | 87% | 264 |
6 | TARR, AW , KHERA, T , HUEGING, K , SHELDON, J , STEINMANN, E , PIETSCHMANN, T , BROWN, RJP , (2015) GENETIC DIVERSITY UNDERLYING THE ENVELOPE GLYCOPROTEINS OF HEPATITIS C VIRUS: STRUCTURAL AND FUNCTIONAL CONSEQUENCES AND THE IMPLICATIONS FOR VACCINE DESIGN.VIRUSES-BASEL. VOL. 7. ISSUE 7. P. 3995 -4046 | 269 | 90% | 8 |
7 | BOSTAN, N , MAHMOOD, T , (2010) AN OVERVIEW ABOUT HEPATITIS C: A DEVASTATING VIRUS.CRITICAL REVIEWS IN MICROBIOLOGY. VOL. 36. ISSUE 2. P. 91 -133 | 314 | 77% | 52 |
8 | BARTENSCHLAGER, R , FRESE, M , PIETSCHMANN, T , (2004) NOVEL INSIGHTS INTO HEPATITIS C VIRUS REPLICATION AND PERSISTENCE.ADVANCES IN VIRUS RESEARCH, VOL. 63. VOL. 63. ISSUE . P. 71 -+ | 357 | 73% | 175 |
9 | BUKH, J , (2016) THE HISTORY OF HEPATITIS C VIRUS (HCV): BASIC RESEARCH REVEALS UNIQUE FEATURES IN PHYLOGENY, EVOLUTION AND THE VIRAL LIFE CYCLE WITH NEW PERSPECTIVES FOR EPIDEMIC CONTROL.JOURNAL OF HEPATOLOGY. VOL. 65. ISSUE . P. S2 -S21 | 258 | 91% | 0 |
10 | SCHEEL, TKH , RICE, CM , (2013) UNDERSTANDING THE HEPATITIS C VIRUS LIFE CYCLE PAVES THE WAY FOR HIGHLY EFFECTIVE THERAPIES.NATURE MEDICINE. VOL. 19. ISSUE 7. P. 837 -849 | 142 | 89% | 201 |
Classes with closest relation at Level 2 |